Cargando…
An update on the status of breast cancer screening in Brazil after the covid-19 pandemic
We have previously reported the impact of covid-19 pandemic on breast cancer screening, in Brazil: among women aged 50–69 years, mammography attendance decreased by 42% in public healthcare (SUS), comparing 2019 and 2020. In this short communication, we wish to present: a) an update of the number of...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Faculdade de Saúde Pública da Universidade de São Paulo
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550160/ https://www.ncbi.nlm.nih.gov/pubmed/36259913 http://dx.doi.org/10.11606/s1518-8787.2022056004545 |
_version_ | 1784805818051330048 |
---|---|
author | Bessa, Jordana de Faria Novita, Guilherme Freitas, Ruffo |
author_facet | Bessa, Jordana de Faria Novita, Guilherme Freitas, Ruffo |
author_sort | Bessa, Jordana de Faria |
collection | PubMed |
description | We have previously reported the impact of covid-19 pandemic on breast cancer screening, in Brazil: among women aged 50–69 years, mammography attendance decreased by 42% in public healthcare (SUS), comparing 2019 and 2020. In this short communication, we wish to present: a) an update of the number of mammograms performed, in 2021; b) an exploratory analysis of the characteristics of the screened population between 2019 and 2021. A total of 1.675.307 mammograms were performed in 2021, nearly 15% lower than pre-pandemic levels. Almost a third, 29.5% of them, had intervals greater than three years. In accordance with our previous study, the number of patients with palpable lumps on physical exam increased. The consequences of postponing breast cancer screening during the pandemic are still uncertain. Unfortunately, as of December 2021, screening attendance has not resumed. On the contrary, our results show an increase in the fraction of women with mammography delayed beyond three years. |
format | Online Article Text |
id | pubmed-9550160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Faculdade de Saúde Pública da Universidade de São Paulo |
record_format | MEDLINE/PubMed |
spelling | pubmed-95501602022-10-13 An update on the status of breast cancer screening in Brazil after the covid-19 pandemic Bessa, Jordana de Faria Novita, Guilherme Freitas, Ruffo Rev Saude Publica Brief Communication We have previously reported the impact of covid-19 pandemic on breast cancer screening, in Brazil: among women aged 50–69 years, mammography attendance decreased by 42% in public healthcare (SUS), comparing 2019 and 2020. In this short communication, we wish to present: a) an update of the number of mammograms performed, in 2021; b) an exploratory analysis of the characteristics of the screened population between 2019 and 2021. A total of 1.675.307 mammograms were performed in 2021, nearly 15% lower than pre-pandemic levels. Almost a third, 29.5% of them, had intervals greater than three years. In accordance with our previous study, the number of patients with palpable lumps on physical exam increased. The consequences of postponing breast cancer screening during the pandemic are still uncertain. Unfortunately, as of December 2021, screening attendance has not resumed. On the contrary, our results show an increase in the fraction of women with mammography delayed beyond three years. Faculdade de Saúde Pública da Universidade de São Paulo 2022-10-05 /pmc/articles/PMC9550160/ /pubmed/36259913 http://dx.doi.org/10.11606/s1518-8787.2022056004545 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Bessa, Jordana de Faria Novita, Guilherme Freitas, Ruffo An update on the status of breast cancer screening in Brazil after the covid-19 pandemic |
title | An update on the status of breast cancer screening in Brazil after the covid-19 pandemic |
title_full | An update on the status of breast cancer screening in Brazil after the covid-19 pandemic |
title_fullStr | An update on the status of breast cancer screening in Brazil after the covid-19 pandemic |
title_full_unstemmed | An update on the status of breast cancer screening in Brazil after the covid-19 pandemic |
title_short | An update on the status of breast cancer screening in Brazil after the covid-19 pandemic |
title_sort | update on the status of breast cancer screening in brazil after the covid-19 pandemic |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550160/ https://www.ncbi.nlm.nih.gov/pubmed/36259913 http://dx.doi.org/10.11606/s1518-8787.2022056004545 |
work_keys_str_mv | AT bessajordanadefaria anupdateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic AT novitaguilherme anupdateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic AT freitasruffo anupdateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic AT bessajordanadefaria updateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic AT novitaguilherme updateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic AT freitasruffo updateonthestatusofbreastcancerscreeninginbrazilafterthecovid19pandemic |